192 related articles for article (PubMed ID: 2820828)
1. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure.
Bassett ML; Mullen KD; Skolnick P; Jones EA
Gastroenterology; 1987 Nov; 93(5):1069-77. PubMed ID: 2820828
[TBL] [Abstract][Full Text] [Related]
2. NIH conference. The gamma-aminobutyric acid A (GABAA) receptor complex and hepatic encephalopathy. Some recent advances.
Jones EA; Skolnick P; Gammal SH; Basile AS; Mullen KD
Ann Intern Med; 1989 Apr; 110(7):532-46. PubMed ID: 2538099
[TBL] [Abstract][Full Text] [Related]
3. Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands.
Gammal SH; Basile AS; Geller D; Skolnick P; Jones EA
Hepatology; 1990 Mar; 11(3):371-8. PubMed ID: 2155865
[TBL] [Abstract][Full Text] [Related]
4. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat.
Bosman DK; van den Buijs CA; de Haan JG; Maas MA; Chamuleau RA
Gastroenterology; 1991 Sep; 101(3):772-81. PubMed ID: 1650320
[TBL] [Abstract][Full Text] [Related]
5. Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?
Mullen KD; Martin JV; Mendelson WB; Bassett ML; Jones EA
Lancet; 1988 Feb; 1(8583):457-9. PubMed ID: 2893876
[TBL] [Abstract][Full Text] [Related]
6. Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist.
Baraldi M; Zeneroli ML; Ventura E; Penne A; Pinelli G; Ricci P; Santi M
Clin Sci (Lond); 1984 Aug; 67(2):167-75. PubMed ID: 6086210
[TBL] [Abstract][Full Text] [Related]
7. Differential responsiveness of cerebellar Purkinje neurons to GABA and benzodiazepine receptor ligands in an animal model of hepatic encephalopathy.
Basile AS; Gammal SH; Mullen KD; Jones EA; Skolnick P
J Neurosci; 1988 Jul; 8(7):2414-21. PubMed ID: 2854841
[TBL] [Abstract][Full Text] [Related]
8. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.
Bansky G; Meier PJ; Riederer E; Walser H; Ziegler WH; Schmid M
Gastroenterology; 1989 Sep; 97(3):744-50. PubMed ID: 2546850
[TBL] [Abstract][Full Text] [Related]
9. Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy.
Rothstein JD; Olasmaa M
Neurochem Res; 1990 Feb; 15(2):193-7. PubMed ID: 2159124
[TBL] [Abstract][Full Text] [Related]
10. Hepatic encephalopathy, GABA-ergic neurotransmission and benzodiazepine receptor ligands.
Jones EA; Basile AS; Skolnick P
Adv Exp Med Biol; 1990; 272():121-34. PubMed ID: 1966504
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the presence of a benzodiazepine receptor binding substance in cerebrospinal fluid of a rabbit model of hepatic encephalopathy.
Mullen KD; Martin JV; Mendelson WB; Kaminsky-Russ K; Jones EA
Metab Brain Dis; 1989 Dec; 4(4):253-60. PubMed ID: 2557531
[TBL] [Abstract][Full Text] [Related]
12. The contribution of endogenous benzodiazepine receptor ligands to the pathogenesis of hepatic encephalopathy.
Basile AS
Synapse; 1991 Feb; 7(2):141-50. PubMed ID: 1849322
[TBL] [Abstract][Full Text] [Related]
13. [Electroencephalographic study of the effect of a benzodiazepine antagonist in hepatic encephalopathy].
Pidoux B; Zylberberg P; Valla D; Opolon P
Neurophysiol Clin; 1989 Dec; 19(6):469-76. PubMed ID: 2559309
[TBL] [Abstract][Full Text] [Related]
14. The spinal GABA system modulates burst frequency and intersegmental coordination in the lamprey: differential effects of GABAA and GABAB receptors.
Tegnér J; Matsushima T; el Manira A; Grillner S
J Neurophysiol; 1993 Mar; 69(3):647-57. PubMed ID: 8385187
[TBL] [Abstract][Full Text] [Related]
15. [Benzodiazepine antagonists in the treatment of heptic encephalopathy].
Ferenci P; Grimm G
Leber Magen Darm; 1989 Dec; 19(6):322-5. PubMed ID: 2575692
[TBL] [Abstract][Full Text] [Related]
16. Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure.
Basile AS; Hughes RD; Harrison PM; Murata Y; Pannell L; Jones EA; Williams R; Skolnick P
N Engl J Med; 1991 Aug; 325(7):473-8. PubMed ID: 1649403
[TBL] [Abstract][Full Text] [Related]
17. Visual evoked potentials in a rabbit model of hepatic encephalopathy. II. Comparison of hyperammonemic encephalopathy, postictal coma, and coma induced by synergistic neurotoxins.
Pappas SC; Ferenci P; Schafer DF; Jones EA
Gastroenterology; 1984 Mar; 86(3):546-51. PubMed ID: 6693016
[TBL] [Abstract][Full Text] [Related]
18. Brain GABA and benzodiazepine receptors in hepatic encephalopathy.
Butterworth RF
Rev Invest Clin; 1990 Jul; 42 Suppl():137-40. PubMed ID: 19256153
[TBL] [Abstract][Full Text] [Related]
19. Do benzodiazepine ligands contribute to hepatic encephalopathy?
Jones EA; Basile AS; Yurdaydin C; Skolnich P
Adv Exp Med Biol; 1993; 341():57-69. PubMed ID: 8116487
[TBL] [Abstract][Full Text] [Related]
20. Visual evoked potentials in a rabbit model of hepatic encephalopathy. I. Sequential changes and comparisons with drug-induced comas.
Schafer DF; Pappas SC; Brody LE; Jacobs R; Jones EA
Gastroenterology; 1984 Mar; 86(3):540-5. PubMed ID: 6693015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
